Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Assets (2021 - 2023)

Cullinan Therapeutics (CGEM) has 3 years of Return on Assets data on record, last reported at 0.31% in Q3 2023.

  • For Q3 2023, Return on Assets fell 43.0% year-over-year to 0.31%; the TTM value through Sep 2023 reached 0.31%, down 43.0%, while the annual FY2022 figure was 0.22%, 43.0% up from the prior year.
  • Return on Assets reached 0.31% in Q3 2023 per CGEM's latest filing, down from 0.28% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.16% in Q2 2022 and bottomed at 0.31% in Q3 2023.
  • Average Return on Assets over 3 years is 0.08%, with a median of 0.14% recorded in 2021.
  • The widest YoY moves for Return on Assets: up 35bps in 2023, down -44bps in 2023.
  • A 3-year view of Return on Assets shows it stood at 0.15% in 2021, then soared by 198bps to 0.15% in 2022, then crashed by -308bps to 0.31% in 2023.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.31% in Q3 2023, 0.28% in Q2 2023, and 0.11% in Q1 2023.